Form 4: VIAVI SVP Sells Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


VIAVI Solutions SVP of Global Sales, Gary W. Staley, sold a total of 22,784 shares of common stock on February 2, 2026, under a pre-arranged 10b5-1 trading plan.

Summary

  • Gary W. Staley, SVP Global Sales NSE at VIAVI SOLUTIONS INC. (VIAV), reported changes in beneficial ownership.
  • On February 2, 2026, Staley sold 5,646 shares of common stock at a weighted average price of $25.85 per share.
  • On the same date, Staley sold an additional 17,138 shares of common stock at a weighted average price of $25.82 per share.
  • These transactions were executed pursuant to a Rule 10b5-1(c) trading plan.
  • Following these transactions, Staley beneficially owns 203,552 shares of VIAVI SOLUTIONS INC. common stock.
  • The total beneficial ownership includes exempt purchases of 1,104 shares on January 31, 2018, and 2,041 shares on January 30, 2026, under the Employee Stock Purchase Plan (ESPP).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While an insider sale can sometimes be perceived negatively, the execution under a 10b5-1 plan suggests a pre-planned portfolio management activity rather than a reaction to new information.

Positives

  • The transactions were executed under a Rule 10b5-1 trading plan, indicating pre-scheduled sales rather than a reaction to immediate company news.

Negatives

  • An insider, the SVP Global Sales, sold a significant number of shares totaling 22,784 shares.

Future Outlook

The filing does not contain any forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that insider sales, especially those executed under a 10b5-1 plan, are common for executives managing their personal portfolios and do not necessarily reflect a change in company fundamentals or industry outlook. However, a sale by a senior sales executive could be viewed with caution by some investors, depending on the broader market and company-specific context.

Comparison to Industry Standards

  • Form 4 filings are standard regulatory disclosures for insider transactions across all publicly traded companies.
  • The execution of sales under a Rule 10b5-1 plan is a common practice among executives to mitigate accusations of trading on material non-public information, aligning with best practices for corporate governance in the U.S. market.

Stakeholder Impact

  • Shareholders: The sale by a senior executive could be interpreted differently by investors, potentially leading to minor short-term sentiment shifts, though the 10b5-1 plan mitigates concerns of opportunistic selling.

Key Dates

DateDescription
01/31/2018Exempt purchase of 1,104 shares under ESPP plan.
01/30/2026Exempt purchase of 2,041 shares under ESPP plan.
02/02/2026Date of common stock sales by Gary W. Staley.
02/03/2026Date the Form 4 was signed by attorney-in-fact.

Recommendation

hold

The filing reports a routine insider stock sale executed under a pre-arranged 10b5-1 plan. This type of transaction is common for executives managing their personal finances and typically does not signal a change in the company's fundamental outlook. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

VIAVI SOLUTIONS INC., VIAV, Form 4, Insider Trading, Stock Sale, Gary W. Staley, 10b5-1 Plan, SVP Global Sales

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.